CDKN1B and neoplasm: In agreement with the growth inhibition, immunohistochemical analysis on tumor sections from mice treated with the drug showed statistically significantly higher expression of p21, p27 and activation of caspase 3 and lower expression of the proliferation marker Ki67 vs control vehicle tumors (Fig. 4D, E).